Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RP103 PK/PD in Nephropathic Cystinosis
NCT00872729Phase 2Completed
- Sponsor
- Amgen
- Start
- May 2009
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cysteamine in nephropathic cystinosis, sponsored by Amgen. Started May 2009; status: completed.
02
Drugs
cysteamine
03
Conditions
nephropathic cystinosis
Beyond the preview
Go deeper on NCT00872729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00872729.